LEWISTON, ME – 11-13-2012 — MD Spiro a Micro Direct company proudly announces the launch of their new spirometry eCommerce website platform for doctors and their practice. MD Spiro specializes in the sale and support of pulmonary diagnostic medical device products and can now sell direct to a doctor’s practice any time of the day. The website is designed to help doctors understand the importance of incorporating spirometry into their practice to help diagnose and treat patients that may suffer from Chronic Obstructive Pulmonary Disease (COPD), asthma, and other chronic conditions that affect breathing.
Spirometry may also be used periodically to check how well your lungs are working once the patient has been treated for a chronic lung condition. The importance of being able to measure how a patient’s lungs are functioning is crucial in the care of patients with breathing conditions and allergies.
Pulmonary lung function testing has grown as an industry in sports medicine and general practice across the world. It is good medicine to correctly diagnose and treat patients more accurately and effectively in the convenience of a doctor’s office. MD Spiro sells easy-to-use desktop, handheld, and pocket spirometers, peak flow meters, calibration equipment, and the disposable products that support the equipment.
“Without the proper equipment in your doctor’s office, you cannot correctly and effectively treat your patient. We feel that it is crucial for our products to be in every doctor’s office and to teach doctors and patients alike about the importance of spirometry in medical practice,” said David Staszak, Owner and CEO of MD Spiro and Micro Direct.
For more information about MD Spiro and their parent organization, Micro Direct, please visit their website at www.mdspiro.com.
About MD Spiro
MD Spiro was established in 1993. MD Spiro offers medical devices from the pulmonary diagnostic field that helps to evaluate and diagnose the patients they treat. Their sales and support staff have over 100 years of combined experience in the medical equipment industry. The staff is ready to advise customers on the best products for their practice. They pride themselves on being available for their customers after the sale to provide technical support on equipment operation, proper patient testing techniques and third party insurance billing.
# # #Read more..
Diagnosis of chronic obstructive pulmonary disease (COPD) and its severity determination is based on spirometry. The quality of spirometry is crucial.
Our aim was to assess the quality of spirometry performed using a spirometer with automated feedback and quality control in a general practice setting in Switzerland and to determine the prevalence of airflow limitation in smokers aged > or =40 years.
Current smokers > or =40 years of age were consecutively recruited for spirometry testing by general practitioners. General practitioners received spirometry training and were provided with an EasyOne spirometer. Spirometry tests were assigned a quality grade from A to D and F, based on the criteria of the National Lung Health Education Program. Only spirometry tests graded A-C (reproducible measurements) were included in the analysis of airflow limitation.
A total of 29,817 spirometries were analyzed. Quality grades A-D and F were assigned to 33.9, 7.1, 19.4, 27.8 and 11.8% of spirometries, respectively. 95% required < or =5 trials to achieve spirometries assigned grade A. The prevalence of mild, moderate, severe and very severe airway obstruction in individuals with spirometries graded A-C was 6, 15, 5 and 1%, respectively.
Spirometries in general practice are of acceptable quality with reproducible spirometry in 60% of measurements. Airway obstruction was found in 27% of current smokers aged > or =40 years. Office spirometry provides a simple and quick means of detecting airflow limitation, allowing earlier diagnosis and intervention in many patients with early COPD.
Respiration. 2010;79(6):469-74. Epub 2009 Sep 26.
Quality of spirometry in primary care for case finding of airway obstruction in smokers.
Leuppi JD, Miedinger D, Chhajed PN, Buess C, Schafroth S, Bucher HC, Tamm M.
Clinic for Pneumology, University Hospital, Basel, Switzerland
Professional societies have encouraged primary care providers to conduct spirometry testing for the detection of chronic obstructive pulmonary disease (COPD). In spite of this effort, the success rate is unacceptably low. Simple flow-sensing spirometers have technical flaws that can cause misreadings, and they are rarely checked for accuracy. When spirometry is performed by an experienced technologist, and when payment is made on the criterion of quality, the success rate for adults and school-aged children can be as high as 90%. But testing remains a challenge for younger children and the elderly. Regular feedback for the technologist about their testing results is essential. Even with an accurate spirometer, an able patient, and a skilled technologist, the ordering physician may wrongly interpret the data. Use of spirometry in primary care will continue to be problematic unless high quality testing is tied to reimbursement. Using FEV(1) or peak flow measurements to rule out airway abnormality in the majority of patients, followed by referral for more sophisticated studies in those remaining, may be the best approach. Respiratory therapists should engage in this effort.